ANGIO-SEALĀ® (VIP Vascular Closure Device)
PRODUCT OVERVIEW

BIOABSORBABLE COMPONENTS
The device creates a mechanical seal by sandwiching the arteriotomy between a bioabsorbable anchor and collagen sponge, which dissolve in 60 to 90 days.
Three bioabsorbable components actively seal the arteriotomy:
- Anchor: Bioabsorbable co-polymer anchor placed against the inside of the vessel wall
- Collagen: Placed on top of the arteriotomy in the tissue tract
- Suture: Cinches the anchor and collagen together to form a secure seal.
LOCATE THE ARTERY
- Exchange the procedure sheath with the Angio-Seal locator system.
- Blood flow through the locator visually confirms proper sheath position in the artery.
SET THE ANCHOR
- Insert the Angio-Seal VIP device into the sheath until you hear a āclick.ā
- Gently pull back on the locking cap until you hear another āclick.ā
- The anchor is now locked in place and device is ready to be deployed.
SEAL THE PUNCTURE
- Gently pull back on the Angio-Seal VIP device until the suture has stopped spooling.
- Maintain upward tension on the device and gently advance the compaction tube until resistance is felt.
- Cut the suture and remove the device.
ANGIO-SEAL VIP PRODUCT CODES
| Part Number | French Size | Guidewire Diameter (in) |
| 610130 | 6Fr | .035 Wire |
| 610131 | 8Fr | .038 Wire |
REFERENCES
RX ONLY. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use.Ā
- Nash JE, Evans DG. (1999). The AngioāSeal hemostatic puncture closure device. Concept and experimental results. Herz, 24(8), 597ā606.
- Per Instructions For Use ASIN0004 revision 2018-09-01.
Indications:
TheĀ Angio-Seal Vascular Closure Device product family, including the VIP and Evolution platforms, is indicated for use in closing and reducing time to hemostasis of the femoral arterial puncture site in patients who have undergone diagnostic angiography procedures or interventional procedures using an 8 French or smaller procedural sheath for the 8 F Angio-Seal device and a 6 French or smaller procedural sheath for the 6 F Angio-Seal device.Ā The Angio-Seal VIP and Evolution platform devices are also indicated for use to allow patients who have undergone diagnostic angiography to safely ambulate as soon as possible after sheath removal and device placement, as well as to allow patients who have undergone an interventional procedure to safely ambulate after sheath removal and device placement.
Important Safety Information:
Possible adverse events for vascular closure devices include, but are not limited to: bleeding or hematoma, AV fistula or pseudoaneurysm, infection, allergic reaction, foreign body reaction, inflammation or edema. This device should only be used by a licensed physician (or other health care professional authorized by or under the direction of such physician) possessing adequate instruction in the use of the device, e.g., participation in an Angio-Seal physician instruction program or equivalent.
ANGIO-SEALĀ® (VIP Vascular Closure Device)
Related products
-
CLOSUREFAST
ClosureFastā¢Ā
procedureMinimally invasive thermal
treatment for vein disease
and varicose veins.
The ClosureFast procedure uses radiofrequency energy or heat to close the diseased vein, which redirects blood flow to healthyĀ veins, relieving symptoms.Before the procedure
You will have an ultrasound imaging exam of the leg beingĀ treated. This exam is important for assessing the diseasedĀ superficial vein and planning the procedure.
During the procedure
Your doctor will discuss the procedure with you. Here is a brief summary of what to expect:
- The ClosureFast procedure is performed on an outpatient basis. Your doctor will perform the ClosureFast procedure. Using anĀ ultrasound, your doctor will position a catheter in the diseased vein through a small opening in the skin.
- The small catheter delivers heat to the vein wall, causing it to shrink and seal the vein. Once the diseased vein is closed, blood will reroute itself to other healthy veins.
After the procedure
- You will be taken to the recovery area to rest.
- Following the procedure, your doctor will apply a simpleĀ bandage over the insertion site and will give you compressionĀ stockings to aid in the healing process. Your doctor may encourage you to walk and to refrain from extended standing and strenuous activities for a period of time. The average patient typically resumes normal activities within a few days.1,2
- Your doctor will recommend follow-up care as needed.
-
Benefits of the ClosureFast procedure
- Relief of symptoms after two days, with a noticeable improvement in one to two week
- Minimally invasive outpatient procedure
- Less pain and bruising than laser treatment
- Faster recovery than laser treatment
- Proven results with positive patient experience
Ā
- Rapid recovery ā on average, patients resume normal activities within a few days
- Lasting results ā the only radiofrequency energy procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at five years.4
Adverse events can include nerve injury, hematoma, phlebitis, thrombosis, and/or pulmonary embolism.
Type of therapy
Thermal shrinkage of the vein wall with radiofrequency energy or heatInpatient or outpatient procedure
Outpatient procedureOne- versus two-leg treatment
Typically, each leg will be treated in separate appointmentsNeedle sticks required
One needle stick for vein access.Ā Typically, 5 to 10 needle sticks for anesthesia.Ā
Typical post-treatment recovery
Healing of vein access site, anesthetic needleĀ stick sites, and alsoĀ healing ofĀ ablated vein sectionCompression hose
Required for approximately one weekProcedure success rate
91.9% after five years4
ClosureFast procedure FAQ
Is the ClosureFast procedure painful?
Most patients report feeling little, if any, pain during the ClosureFast procedure.3Ā Your doctor will give you a local or regionalĀ anesthetic to numb the treatment area.
When can I return to normal activity?
Patients treated with the ClosureFast procedure may resume normal activity more quickly than patients who undergo surgical veinĀ stripping or laser ablation. With the ClosureFast procedure, the average patient typically resumes normal activity within a few days.2Ā For a few weeks following the treatment, your vein specialist may recommend a regular walking regimen and suggest you refrainĀ from strenuous activities (heavy lifting, for example) or prolonged periods of standing.
When will my symptoms improve?
Most patients report relief of symptoms after two days, with a noticeable improvement in one to two weeks.
Is there any scarring, bruising, or swelling after the procedure?
Most patients report limited to no scarring, bruising, or swelling following the ClosureFast procedure.3
How is the ClosureFast procedure different from endovenous lasers?
Both Closure Fast and lasers use thermal technology to deliver heat into the diseased vein, but they each use a different method of delivery. Despite their similarity in using heat, a 2009 study showed that the ClosureFast procedure is associated with lower rates of pain, bruising, and complications and a faster improvement in patientsā quality of life when compared to 980 nm laser ablation.4
How is the Closure FastĀ procedure different from vein stripping?
During vein stripping, incisions are made in the groin and calf, and a tool is threaded through the diseased vein to pull the vein outĀ of the leg. With the ClosureFast procedure, only one small incision is made at the insertion site and the vein is then treated and leftĀ in place. ClosureFast is a minimally invasive approach that reduces the likelihood of pain and bruising, associated with vein strippingĀ surgery.1
Is the ClosureFast procedure covered by insurance?
Many patients have access to the ClosureFast procedure through their insurance coverage plan. Insurance companies detail access to the ClosureFast procedure and other radiofrequency ablation procedures in coverage policies for varicose veins or chronic venous insufficiency. As with all healthcare procedures, you may also have some cost associated with receiving treatment, such as a copay or coinsurance. Please reach out to your insurance company to discuss your specific plan coverage and potential costs prior to seeking treatment
-
EUPHORA SEMICOMPLIANT BALLOON CATHETER
Euphora⢠semicompliant balloon
Balloon Dilatation Catheter
Euphora⢠semicompliant balloon dilatation catheter complements your expertise and provides uncompromising performance in the moment you need it most.
OVERVIEW
Advancing Innovation through Partnership
To develop the Euphora⢠low-profile semicompliant balloon dilatation catheter, we partnered with nearly 2,000 interventional cardiologists and cath lab professionals. The result is:
- Superior deliverability1
- Superb Kissing Balloons Technique (KBT) performance2
- The lowest crossing profile compared to leading competitors3
PRODUCT DETAILS
What Makes the Euphora Balloon an Excellent Choice?
ORDERING INFORMATION
BALLOON LENGTHS 6, 10, 12, AND 15 MM
Ā 1.50 EUP1506X EUP1510X EUP1512X EUP1515X Ā 2.00 EUP2006X EUP2010X EUP2012X EUP2015X Ā 2.25 EUP22506X EUP22510X EUP22512X EUP22515X Ā 2.50 EUP2506X EUP2510X EUP2512X EUP2515X Ā 2.75 EUP27506X EUP27510X EUP27512X EUP27515X Ā 3.00 EUP3006X EUP3010X EUP3012X EUP3015X Ā 3.25 EUP32506X EUP32510X EUP32512X EUP32515X Ā 3.50 EUP3506X EUP3510X EUP3512X EUP3515X Ā 3.75 EUP37506X EUP37510X EUP37512X EUP37515X Ā 4.00 EUP4006X EUP4010X EUP4012X EUP4015X BALLOON LENGTHS 20, 25, AND 30 MM
Ā 1.50 EUP1520X ā ā Ā 2.00 EUP2020X EUP2025X EUP2030X Ā 2.25 EUP22520X EUP22525X ā Ā 2.50 EUP2520X EUP2525X EUP2530X Ā 2.75 EUP27520X EUP27525X ā Ā 3.00 EUP3020X EUP3025X EUP3030X Ā 3.25 EUP32520X EUP32525X ā Ā 3.50 EUP3520X EUP3525X EUP3530X Ā 3.75 EUP37520X EUP37525X ā Ā 4.00 EUP4020X EUP4025X EUP4030X -
EXPORT ADVANCE ASPIRATION CATHETER
EXPORT ADVANCE ASPIRATION CATHETER
Export Advance
Aspiration Catheter
ADVANCING PERFORMANCE
The Export Advance⢠aspiration catheter delivers consistent, high-performing aspiration power when it matters most ā restoring flow and protecting patients.
PRODUCT DETAILSā
Superior Deliverability1
Full-Wall TechnologyĀ provides variable levels of stiffness without joints, for optimalĀ kink resistance and catheter performance.
Dependable Delivery to the Target Site:
- Preloaded stylet enhances shaft stiffnessĀ during catheter delivery, boosting kink resistance, trackability, and pushability2
- Buddy wire compatibilityĀ allows for extra support, when needed.ā
High-performing Aspiration Power:
- Large extraction lumen (0.044″ proximal; 0.043″ distal) increases aspiration power.ā”
- Optimised hub geometry improves flow.ā”
- Soft, short, forward-facing tip design permits excellent particle capture.ā
ORDERING INFORMATION
ADVANCE 6 F min. guide I.D. 0.070″ 0.014 140 - ā¢Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
- Based on bench test data, 2013. Bench test data may not be indicative of clinical performance.
- Based on bench test data vs. Export⢠AP catheter.
- Bench testing vs. Terumo Eliminateā¢* and Eliminateā¢* 3 aspiration catheters, Vascular Solutions ProntoĀ®*Ā LP, ProntoĀ®*Ā V3 and ProntoĀ®*Ā V4 aspiration catheters, MeritĀ®*Ā ASAP aspiration catheter, Kaneka Thrombuster III GR* aspiration catheter, Spectranetics QuickCatā¢* aspiration catheter, IHT Polska HunterĀ®* aspiration catheter, Medrad Possisā¢* Fetchā¢* 2 aspiration catheter, and Hexacath Recover* aspiration catheter. 10093906DOC, 2013. Bench test data may not be indicative of clinical performance.
- Based on animal studies compared with Export⢠AP aspiration catheter without stylet.
-
FINECROSS Microcatheter
FINECROSS® MG Coronary Micro-Guide Catheter
Product Code Catheter Length Distal Hydrophilic Coating Distal Outer Diameter Proximal Outer Diameter Distal Inner Diameter Proximal Inner Diameter Recommended Guidewire Size 35-1430 130cm 70cm 1.8Fr. (0.60mm) 2.6 Fr. (0.87mm) 0.018″ (0.45mm) 0.021″ (0.55mm) 0.014″ (0.36mm) 35-1450 150cm 90cm 1.8Fr. (0.60mm) 2.6 Fr. (0.87mm) 0.018″ (0.45mm) 0.021″ (0.55mm) 0.014″ (0.36mm) PRODUCT OVERVIEW
Coronary microguide catheter for integration of optimal guidewire support, superior trackability and crossability.1,2

TAPERED STAINLESS STEEL BRAID CONSTRUCTION FOR OPTIMAL GUIDEWIRE SUPPORT
FINECROSS MG stainless steel braid construction is designed to provide strength, responsiveness and support for improved pushability to access and cross complex lesions.
13cm FLOPPY DISTAL SEGMENT FOR SUPERIOR TRACKABILITY1
The distal 13 cm is ultra flexible for improved trackability around tight bends and tortuous anatomy.The floppy distal segment is designed to be atraumatic and provide an optimal balance between trackability and safety while navigating through the tortuous anatomy.1
TAPERED OUTER DIAMETER FOR SUPERIOR CROSSABILITY1,2
The outer diameter of the stainless steel shaft tapers from a proximal 2.6Fr. to a distal 1.8Fr. designed for improved crossability and guidewire handling.1,2
DOCUMENTS








Reviews
There are no reviews yet.